Aderson Omar Mourão Cintra Damião Selected Research

Biosimilar Pharmaceuticals

1/2015

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aderson Omar Mourão Cintra Damião Research Topics

Disease

7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2023 - 01/2015
5	Crohn Disease (Crohn's Disease) 01/2023 - 01/2019
5	Ulcerative Colitis 01/2023 - 12/2017
1	Guillain-Barre Syndrome 12/2020
1	COVID-19 06/2020

Drug/Important Bio-Agent (IBA)

4	vedolizumabIBA 08/2022 - 01/2016
2	Infliximab (Remicade)FDA Link 01/2023 - 01/2015
2	Ustekinumab (CNTO 1275)FDA Link 08/2022 - 04/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 12/2017
1	AntibodiesIBA 06/2023
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 08/2022
1	tofacitinibIBA 08/2022
1	SteroidsIBA 06/2020
1	Prednisone (Sone)FDA LinkGeneric 06/2020
1	Adalimumab (Humira)FDA Link 12/2017
1	Monoclonal AntibodiesIBA 12/2017
1	Biosimilar PharmaceuticalsIBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2017
2	Biological Therapy 01/2023 - 01/2019
1	Colectomy 01/2022